de Biase D - Search Results

1

Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens.

Pisapia P, Malapelle U, Roma G, Saddar S, Zheng Q, Pepe F, Bruzzese D, Vigliar E, Bellevicine C, Luthra R, Nikiforov YE, Mayo-de-Las-Casas C, Molina-Vila MA, Rosell R, Bihl M, Savic S, Bubendorf L, de Biase D, Tallini G, Hwang DH, Sholl LM, Vander Borght S, Weynand B, Stieber D, Vielh P, Rappa A, Barberis M, Fassan M, Rugge M, De Andrea CE, Lozano MD, Lupi C, Fontanini G, Schmitt F, Dumur CI, Bisig B, Bongiovanni M, Merkelbach-Bruse S, Büttner R, Nikiforova MN, Roy-Chowdhuri S, Troncone G; Molecular Cytopathology Meeting Group. Pisapia P, et al. Among authors: de biase d, de andrea ce. Cancer Cytopathol. 2019 May;127(5):285-296. doi: 10.1002/cncy.22134. Epub 2019 Apr 25. Cancer Cytopathol. 2019. PMID: 31021538 Free article.

2

Promoter methylation analysis of O6-methylguanine-DNA methyltransferase in glioblastoma: detection by locked nucleic acid based quantitative PCR using an imprinted gene (SNURF) as a reference.

Morandi L, Franceschi E, de Biase D, Marucci G, Tosoni A, Ermani M, Pession A, Tallini G, Brandes A. Morandi L, et al. Among authors: de biase d. BMC Cancer. 2010 Feb 18;10:48. doi: 10.1186/1471-2407-10-48. BMC Cancer. 2010. PMID: 20167086 Free PMC article.

3

Allele specific locked nucleic acid quantitative PCR (ASLNAqPCR): an accurate and cost-effective assay to diagnose and quantify KRAS and BRAF mutation.

Morandi L, de Biase D, Visani M, Cesari V, De Maglio G, Pizzolitto S, Pession A, Tallini G. Morandi L, et al. Among authors: de biase d, de maglio g. PLoS One. 2012;7(4):e36084. doi: 10.1371/journal.pone.0036084. Epub 2012 Apr 30. PLoS One. 2012. PMID: 22558339 Free PMC article.

4

Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysis.

Piana S, Ragazzi M, Tallini G, de Biase D, Ciarrocchi A, Frasoldati A, Rosai J. Piana S, et al. Among authors: de biase d. Hum Pathol. 2013 Apr;44(4):556-65. doi: 10.1016/j.humpath.2012.06.019. Epub 2012 Oct 15. Hum Pathol. 2013. PMID: 23079204

5

Multiple KRAS mutations in pancreatic adenocarcinoma: molecular features of neoplastic clones indicate the selection of divergent populations of tumor cells.

Visani M, de Biase D, Baccarini P, Fabbri C, Polifemo AM, Zanini N, Pession A, Tallini G. Visani M, et al. Among authors: de biase d. Int J Surg Pathol. 2013 Dec;21(6):546-52. doi: 10.1177/1066896912475073. Epub 2013 Feb 19. Int J Surg Pathol. 2013. PMID: 23426962

6

454 next generation-sequencing outperforms allele-specific PCR, Sanger sequencing, and pyrosequencing for routine KRAS mutation analysis of formalin-fixed, paraffin-embedded samples.

Altimari A, de Biase D, De Maglio G, Gruppioni E, Capizzi E, Degiovanni A, D'Errico A, Pession A, Pizzolitto S, Fiorentino M, Tallini G. Altimari A, et al. Among authors: de biase d, d errico a, de maglio g. Onco Targets Ther. 2013 Aug 5;6:1057-64. doi: 10.2147/OTT.S42369. eCollection 2013. Onco Targets Ther. 2013. PMID: 23950653 Free PMC article.

7

Next-generation sequencing of lung cancer EGFR exons 18-21 allows effective molecular diagnosis of small routine samples (cytology and biopsy).

de Biase D, Visani M, Malapelle U, Simonato F, Cesari V, Bellevicine C, Pession A, Troncone G, Fassina A, Tallini G. de Biase D, et al. PLoS One. 2013 Dec 23;8(12):e83607. doi: 10.1371/journal.pone.0083607. eCollection 2013. PLoS One. 2013. PMID: 24376723 Free PMC article.

8

Molecular diagnosis of carcinomas of the thyroid gland.

de Biase D, Visani M, Pession A, Tallini G. de Biase D, et al. Front Biosci (Elite Ed). 2014 Jan 1;6(1):1-14. doi: 10.2741/e685. Front Biosci (Elite Ed). 2014. PMID: 24389136 Free article. Review.

9

Next generation sequencing improves the accuracy of KRAS mutation analysis in endoscopic ultrasound fine needle aspiration pancreatic lesions.

de Biase D, Visani M, Baccarini P, Polifemo AM, Maimone A, Fornelli A, Giuliani A, Zanini N, Fabbri C, Pession A, Tallini G. de Biase D, et al. PLoS One. 2014 Feb 4;9(2):e87651. doi: 10.1371/journal.pone.0087651. eCollection 2014. PLoS One. 2014. PMID: 24504548 Free PMC article.

10

High-sensitivity BRAF mutation analysis: BRAF V600E is acquired early during tumor development but is heterogeneously distributed in a subset of papillary thyroid carcinomas.

de Biase D, Cesari V, Visani M, Casadei GP, Cremonini N, Gandolfi G, Sancisi V, Ragazzi M, Pession A, Ciarrocchi A, Tallini G. de Biase D, et al. J Clin Endocrinol Metab. 2014 Aug;99(8):E1530-8. doi: 10.1210/jc.2013-4389. Epub 2014 Apr 29. J Clin Endocrinol Metab. 2014. PMID: 24780046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

327 results

Search Page

Filters